Management of severe acute asthma in the emergency department

Current Opinion in Critical Care

Volumn 17, Issue 4, 2011, Pages 335-341

  Rowe, Brian H ^a   Sevcik, William ^a   Villa Roel, Cristina ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

asthma; bronchodilators; corticosteroids; magnesium sulfate; prevention

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE PROPIONATE; HYDROCORTISONE SODIUM SUCCINATE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; METHYLPREDNISOLONE SODIUM SUCCINATE; MONTELUKAST; OXYGEN; PLACEBO; PREDNISONE; SALBUTAMOL;

ACUTE ASTHMA; ASTHMA; BRONCHOSPASM; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EMERGENCY WARD; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INHALATION SPACER; INTUBATION; MEDICAL ASSESSMENT; MEDICAL NEBULIZER; META ANALYSIS (TOPIC); METERED DOSE INHALER; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFLAMMATION; REVIEW; SYSTEMATIC REVIEW (TOPIC); TACHYCARDIA; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; VITAL SIGN;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFLAMMATION; MAGNESIUM SULFATE; OXIMETRY; SEVERITY OF ILLNESS INDEX;

EID: 79960838098     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328348bf09     Document Type: Review

References (37)

1. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma: United States, 1960-1995. MMWR CDC Surveill Summ 1998; 47:1-27.
2. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol 2000; 106:493-499. (Pubitemid 32037702)
3. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I: Assessing the economic impact. J Allergy Clin Immunol 2001; 107:3-8. (Pubitemid 32105235)
4. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. CMAJ 1996; 154:821-831. (Pubitemid 26097872)
5. American Lung Association. Trends in asthma morbidity and mortality. American Lung Association Epidemiology & Statistics Unit Research and Program Services; 2010. Washington, DC.
6. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl):S94-S138.
7. Hodder R, Lougheed MD, Rowe BH, et al. Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ 2010; 182:E55-E67.
8. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2010. 2010. http://www.ginasthma.org.
9. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008; 63 (Suppl4):iv1 -iv121.
10. Boulet L-P, Becker A, Berube D, et al., on behalf of the Canadian Asthma Consensus Group. Canadian asthma consensus report. CMAJ 1999; 161: S1-S61.
11. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report 2010; (26):1-31.
12. Rowe BH, Voaklander DC, Wang D, et al. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009; 135:57-65.
13. Worthington JR, Ahuja J. The value of pulmonary function tests in the management of acute asthma. CMAJ 1989; 140:153-156. (Pubitemid 19043156)
14. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006:CD000052.
15. Turner MO, Gafni A, Swan D, Fitz Gerald JM. A review and economic evaluation of bronchodilator delivery methods in hospitalized patients. Arch Intern Med 1996; 156:2113-2118. (Pubitemid 26346970)
16. Camargo CA Jr, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists in the treatment of acute asthma. Cochrane Database Syst Rev 2003:CD001115.
17. Emerman CL, Cydulka RK, McFadden ER. Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest 1999; 115:92-96. (Pubitemid 29047058)
18. Strauss L, Hejal R, Galan G, et al. Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 1997; 155:454-458. (Pubitemid 27085785)
19. Travers A, Jones AP, Kelly K, et al. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001: CD002988.
20. Varia M, Wilson S, Sarwal S, et al., for the Hospital Outbreak Investigation Team. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003; 169:285-292. (Pubitemid 37047056)
21. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999; 34:8-18. (Pubitemid 29295746)
22. Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000; 161:1862-1868. (Pubitemid 30418121)
23. National Asthma Education and Prevention Program. Expert Panel Report II: guidelines for the diagnosis and management of asthma. Clinical practice guidelines. Bethesda, Maryland: National Institutes of Health; 1997.
24. Network BTSSIG. British guideline on the management of asthma. Thorax 2003; 58:1-94.
25. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001:CD002178.
26. Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000:CD001490.
27. Alter HJ, Koepsell TD, Hilty WM. Intravenous magnesium as an adjuvant in acute bronchospasm: a meta-analysis. Ann Emerg Med 2000; 36:191-197.
28. Rowe BH, Camargo CA Jr. The use of magnesium sulfate in acute asthma: rapid uptake of evidence in North American emergency departments. J Allergy Clin Immunol 2006; 117:53-58. (Pubitemid 43017139)
29. Edmonds ML, Camargo CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2000:CD002308.
30. Simons FE. Emergency treatment of anaphylaxis. BMJ 2008; 336:1141-1142. (Pubitemid 351809255)
31. Camargo CA Jr, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003; 167:528-533.
32. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004; 126:1480-1489. (Pubitemid 39525020)
33. Browning J, Atwood B, Gray A. Use of noninvasive ventilation in UK emergency departments. Emerg Med J 2006; 23:920-921. (Pubitemid 44883619)
34. Hess DR, Pang JM, Camargo CA Jr. A survey of the use of noninvasive ventilation in academic emergency departments in the United States. Respir Care 2009; 54:1306-1312.
35. Ram FS, Wellington S, Rowe B, Wedzicha JA. Noninvasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005:CD004360.
36. Penuelas O, Frutos-Vivar F, Esteban A. Noninvasive positive-pressure ventilation in acute respiratory failure. CMAJ 2007; 177:1211-1218. (Pubitemid 350178610)
37. Hodder R, Lougheed MD, Fitz Gerald JM, et al. Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ 2010; 182:265-272.